Pediaatria
Laste ja vastsündinute ravimine ilma vereülekandeta. Vali kõigepealt meditsiiniharu ja seejärel ravivõte. Klõpsa pealkirjal, et avada artikkel või bibliokirje.
Preoperative Patient Evaluation and Transfusion Risk Assessment
Preoperative Planning and Patient Optimization
Multimodality, Interdisciplinary, and Individualized Approach
Preoperative Anemia Management and Optimization of Red Cell Mass
Anticoagulation Management and Reversal
Angiographic Embolization or Vascular Occlusion
Surgical Blood Conservation Techniques
Minimally Invasive Approaches
Management and Optimization of Hemostasis
-
Antifibrinolytic Agents
-
Recombinant Activated Factor VII (rFVIIa)
-
Coagulation Factor Concentrates
-
Desmopressin
-
Topical Hemostatic Agents
-
Viscoelastic Tests to Identify Surgical or Coagulopathic Bleeding
Thermal Management (Prevention of Hypothermia)
Judicious Fluid and Volume Management
Intraoperative Autologous Blood Management
-
Miniaturized Cardiopulmonary Bypass (Perfusion) Circuits
-
Vere kogumine ja reinfusioon
-
Acute Normovolemic Hemodilution
-
Retrograde Autologous Priming
-
Ultrafiltration
Restricted Diagnostic Phlebotomy to Avoid Iatrogenic Anemia
Postoperative Anemia Management
Optimization of Patients’ Tolerance of Anemia
Acceptance of Moderate Normovolemic Anemia
Resource-Limited Settings
Adverse Effects of Substantial Bleeding
Transfusion Risks and Uncertainties
Clinical Outcomes
Economic Outcomes
Prenatal Planning to Prevent Transfusion
Multimodality, Interdisciplinary, and Individualized Approach
Management of Anemia of Prematurity
-
Delayed Cord Clamping
-
Using Residual Cord Blood for Blood Tests
-
Erythropoiesis-Stimulating Agents
-
Tolerance of Anemia in Low-Birth-Weight Infants
Restricted Diagnostic Phlebotomy to Avoid Iatrogenic Anemia
Hyperbilirubinemia Management
Thrombocytopenia Management
Management and Optimization of Hemostasis
Prevention of Drug-Induced Anemia or Thrombocytopenia
Bacterial Sepsis
Preoperative Anemia Management and Optimization of Red Cell Mass
Acceptance of Moderate Normovolemic Anemia
Tolerance of Thrombocytopenia
Resource-Limited Settings
Transfusion Risks and Uncertainties
Multimodality, Interdisciplinary, and Individualized Approach
Anemia Management
Thrombocytopenia Management
Management and Optimization of Hemostasis
-
Antifibrinolytic Agents
-
Recombinant Activated Factor VII (rFVIIa)
-
Desmopressin
-
Topical Hemostatic Agents
Neutropenia Management
Individualized/Modified Chemotherapy (Dose Adjustment or Delay)
Immunotherapy
Restricted Diagnostic Phlebotomy to Avoid Iatrogenic Anemia
Acceptance of Moderate Normovolemic Anemia
Transfusion Risks and Uncertainties
Clinical Outcomes
Preoperative Patient Evaluation and Transfusion Risk Assessment
Preoperative Planning and Patient Optimization
Multimodality, Interdisciplinary, and Individualized Approach
Preoperative Anemia Management and Optimization of Red Cell Mass
Management and Optimization of Hemostasis
-
Antifibrinolytic Agents
-
Recombinant Activated Factor VII (rFVIIa)
-
Coagulation Factor Concentrates
-
Viscoelastic Tests to Identify Surgical or Coagulopathic Bleeding
Intraoperative Autologous Blood Management
Anesthetic Blood Conservation Techniques
Economic Outcomes
Preoperative Patient Evaluation and Transfusion Risk Assessment
Preoperative Planning and Patient Optimization
Multimodality, Interdisciplinary, and Individualized Approach
Preoperative Anemia Management and Optimization of Red Cell Mass
Thrombocytopenia Management
Management and Optimization of Hemostasis
-
Antifibrinolytic Agents
-
Recombinant Activated Factor VII (rFVIIa)
-
Coagulation Factor Concentrates
-
Desmopressin
-
Viscoelastic Tests to Identify Surgical or Coagulopathic Bleeding
Thermal Management (Prevention of Hypothermia)
Judicious Fluid and Volume Management
Intraoperative Autologous Blood Management
Anesthetic Blood Conservation Techniques
Restricted Diagnostic Phlebotomy to Avoid Iatrogenic Anemia
Postoperative Anemia Management
Optimization of Patients’ Tolerance of Anemia
Acceptance of Moderate Normovolemic Anemia
Resource-Limited Settings
Adverse Effects of Substantial Bleeding
Transfusion Risks and Uncertainties
Clinical Outcomes
Economic Outcomes
Preoperative Patient Evaluation and Transfusion Risk Assessment
Preoperative Planning and Patient Optimization
Multimodality, Interdisciplinary, and Individualized Approach
Preoperative Anemia Management and Optimization of Red Cell Mass
Thrombocytopenia Management
Surgical Blood Conservation Techniques
Management and Optimization of Hemostasis
-
Antifibrinolytic Agents
-
Recombinant Activated Factor VII (rFVIIa)
-
Viscoelastic Tests to Identify Surgical or Coagulopathic Bleeding